Fundraising Fox
Hui Tian
InvestorPartner at The Column Group · Executive at Topo Therapeutics · Board director at Judo Bio
San Mateo, California
Writes $100K – $5M checks · typically $1.5M
Find your path to Hui
284 people in our graph share verified history with Hui — schools, employers, funds. One of them is your warm intro.
Helen KimunlockedHui: together at NGM Bio (2009–2014)
×5Hui: together at NGM Bio
×6Hui: together at The Column Group
About
Joined The Column Group in 2022 as a Venture Partner. A founding member of NGM Biopharmaceuticals where he served as SVP of Research; holds a PhD from UT Southwestern.
Contact· self-published, not guessed
Executive at Topo Therapeutics
Intro paths
→
In turn, Hui can intro founders to Topo Therapeutics's investors below.
Board director at Judo Bio
Intro paths
→
In turn, Hui can intro founders to Judo Bio's investors below.
Judo Bio's investors · 5
Co-founders at Judo Bio
AF
Andrew FraleyCo-founder
AS
Alfica Sehgal
Experience
- The Column GroupPartnercurrent2024 — present
- The Column GroupVenture Partner2022 — 2024San Francisco Bay Area
- NGM BiopharmaceuticalsSenior Vice President Research2018 — 2022
- NGM BiopharmaceuticalsVice President of Research2011 — 2018
- NGM BiopharmaceuticalsDirector of Research2008 — 2011
- AmgenScientific Director1999 — 2008
- TularikResearch Investigator1999 — 2004
- Harvard UniversityPostdoctoral Fellow1998 — 1999
Colleagues at The Column Group
Aadit Shah
Principal at The Column Group
Arnav Mehta, MD, PhD
Venture Partner at The Column Group
Betty Liu
Swanson Fellow at The Column Group
Brooke Sorenson
Administrative Coordinator at The Column Group
Carla Daniel
Partner at The Column Group
Charles Sawyers
Science Partner at The Column Group
Charles Zuker
Science Partner at The Column Group
Craig Parker
Venture Partner at The Column Group
Network2
Investors connected to Hui in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Hui Tian?
- Joined The Column Group in 2022 as a Venture Partner. A founding member of NGM Biopharmaceuticals where he served as SVP of Research; holds a PhD from UT Southwestern.
- Where does Hui Tian work?
- Hui Tian is Partner at The Column Group and Executive at Topo Therapeutics and Board director at Judo Bio.
- What check size does Hui Tian write?
- Hui Tian typically writes checks of $100K – $5M.
- Where did Hui Tian go to school?
- Hui Tian studied at UT Southwestern Medical Center; The University of Texas Southwestern Medical School (PhD, Molecular and Cellular Biology); University of Science and Technology of China (BS, Biology).
Same school
Also attended UT Southwestern Medical Center19
Lauren TyraInvestor at Green Park & Golf VenturesDeng MaoInvestment Manager at Yonjin Venture LLCOscar MoralezFounder and Managing Partner at Boomerang VenturesJill MooneyAdvisor at Avalon BioVenturesUgur EskiocakFounder / EIR at 82VSAbby AlbrightCo-Founder and Investor at WXR Fund
+ 13 more
Also attended The University of Texas Southwestern Medical School9
Casey CunninghamPartner and Chief Scientific Officer at Sante VenturesAndreas LoewPartner at Scion Life SciencesShih KhooCEO at ClavystBioKhoo ShihChief Executive Officer at ClavystBioJennifer ShufordDeputy Director and Chief Medical Officer at Centers for Disease Control and Prevention (CDC)Corey Fish, MDFounder at Brave Care
+ 3 more
Also attended University of Science and Technology of China38
Prof. Shanhui FanInvestor at G Vision CapitalJeff LinPartner at iGlobe PartnersRaymond FengTechnical Partner at FactionLei ZhangInvestor at Walnut Venture AssociatesWeikeng ChenResearch Partner at L2 Iterative Ventures (L2IV)Charlene LiDirector of Strategic Partnerships at TSVC
+ 32 more
Shared employers
Also worked at The Column Group12
Tim KutzkeyManaging Partner at The Column GroupPeter SvennilsonFounder / Managing Partner at The Column GroupLeon ChenPartner at The Column GroupSarah HymowitzPartner at The Column GroupJeff GoaterPartner at The Column GroupCarla DanielPartner at The Column Group
+ 6 more
Also worked at NGM Biopharmaceuticals6
Also worked at Amgen188
Parker ConradCo-founder & CEO of RipplingSeth LieblichInvestment Team at 8VCSean BruichChief Technology Officer at Flare Capital PartnersSteph ScottVice President at Questa CapitalBeth SeidenbergFounding Managing Director at Westlake Village BioPartnersKelli McKeirnanDirector of Administration at Westlake Village BioPartners
+ 182 more
Also worked at Tularik6
Lalo FloresVenture Partner at Scion Life SciencesMonique SchiersingSenior Investment Director at Roche Venture FundKarl HandelsmanInvestor at Codon CapitalCarla DanielPartner at The Column GroupDavid V. GoeddelManaging Partner at The Column GroupShahid NimjeeCo-founder, Chief Scientific Officer and Stroke Clinical Lead at Basking Biosciences
